PubMedCrossRef 24. Heym B, Honore N, Truffot-Pernot
C, Banerjee A, Schurra C, Jacobs WR Jr, van Embden JD, Grosset JH, Cole ST: Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study. Lancet 1994, 344:293–298.PubMedCrossRef 25. Zanden AG, Te Koppele-Vije EM, Vijaya Bhanu N, Van Soolingen D, Schouls LM: Use of DNA extracts from Ziehl-Neelsen-stained slides for molecular detection of rifampin resistance and spoligotyping of Mycobacterium tuberculosis . J Clin Microbiol 2003, 41:1101–1108.CrossRef 26. Brudey K, Driscoll JR, Rigouts L, SCH727965 Prodinger WM, Gori A, Al-Hajoj SA, Allix C, Aristimuño L, Arora J, Baumanis V, Binder L, Cafrune P, Cataldi A, Cheong S, Diel R, Ellermeier C, Evans JT, Fauville-Dufaux M, Ferdinand S, Garcia de Viedma Pictilisib D, Garzelli C, Gazzola L, Gomes HM, Guttierez MC, Hawkey PM, van Helden PD, Kadival GV, Kreiswirth BN, Kremer K, Kubin M, Kulkarni SP, Liens B, Lillebaek T, Ho ML, Martin C, Martin C, Mokrousov I, Narvskaïa O, Ngeow YF, Naumann L, Niemann S, Parwati I, Rahim Z, Rasolofo-Razanamparany V, Rasolonavalona T, Rossetti ML, Rüsch-Gerdes S, Sajduda A, Samper S, Shemyakin IG, Singh UB, Somoskovi A, Skuce RA, van Soolingen D, Streicher EM, Suffys PN, Tortoli E, Tracevska T, Vincent V, Victor TC, Warren RM, Yap SF, Zaman K, Portaels F, Rastogi N, Sola C: Mycobacterium tuberculosis complex genetic
diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiol 2006, 6:23.PubMedCrossRef 27. Ramaswamy SV, Dou SJ, Rendon A, Yang Z, MLN8237 cell line Cave MD, Graviss EA: Genotypic analysis of multidrug-resistant Mycobacterium tuberculosis isolates from Monterrey, Mexico. J Med Microbiol 2004, 53:107–113.PubMedCrossRef 28. Viader-Salvado JM, Thymidylate synthase Luna-Aguirre CM, Reyes-Ruiz JM, Valdez-Leal R, del Bosque-Moncayo Mde L, Tijerina-Menchaca R, Guerrero-Olazarán M: Frequency of mutations in rpo B and codons 315 and 463 of kat G in rifampin- and/or isoniazid-resistant Mycobacterium
tuberculosis isolates from northeast Mexico. Microb Drug Resist 2003, 9:33–38.PubMedCrossRef 29. Perez-Martinez I, Ponce-De-Leon A, Bobadilla M, Villegas-Sepulveda N, Perez-Garcia M, Sifuentes-Osornio J, González-y-Merchand JA, Estrada-García T: A novel identification scheme for genus Mycobacterium , M. tuberculosis complex, and seven mycobacteria species of human clinical impact. Eur J Clin Microbiol Infect Dis 2008, 27:451–459.PubMedCrossRef 30. Global tuberculosis control 2009. Epidemiology strategy financing [http://www.who.int/tb/publications/global_report/2009/pdf/full_report.pdf] 31. Cosivi O, Grange JM, Daborn CJ, Raviglione MC, Fujikura T, Cousins D, Robinson RA, Huchzermeyer HF, de Kantor I, Meslin FX: Zoonotic tuberculosis due to Mycobacterium bovis in developing countries. Emerg Infect Dis 1998, 4:59–70.PubMedCrossRef 32.